ART's SoftScan Optical Breast Imaging System Meets Primary Endpoint in Landmark Tissue Characterization Study
14th Nov 2006, 13:29 GMT
ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical industries, announced...
ART's SoftScan Optical Breast Imaging System Meets Primary Endpoint in Landmark Tissue Characterization Study related news:
- ART Advanced Research Technologies Inc.: ART's SoftScan Optical Breast Imaging System Meets Primary Endpoint in Landmark Tissue Characterization Study — Market Wire - Pharmaceuticals and Biotech
- ART Advanced Research Technologies Announces 2006 Third Quarter Financial Results — ArriveNet : Health
- Mayo Clinic study observes normal aging process lowers breast cancer risk — EurekAlert! - Breaking News
- Surgical Biopsy May Reveal Cancer In Women With Rare But Benign Breast Condition — ScienceDaily Headlines
- ART Advanced Research Technologies Inc.: ART Advanced Research Technologies Announces 2006 Third Quarter Financial Results — Market Wire - Earnings Reports
- Favrille Drug Misses Secondary Target — Pharmaceuticals News from StratCenter.com
- Sagemark Expands PET Imaging Portfolio — Positron Emission Tomography (PET) News from StratCenter.com
- LympheDIVAs: Fashionable way to treat lymphedema — The Cancer Blog
- Red meat linked to some breast cancers: study — Reuters: Health
- Red meat linked to some breast cancers: study (Reuters) — Yahoo! News: Most Recommended
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL